Author

Christophe Piesse

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Organism:human· 1

Frequent Co-Authors

Adrien Bouchet· 1 shared Anna Velia Vázquez-MarmolejoiD· 1 shared Célia Delhaye· 1 shared Constance AuvynetiD· 1 shared Duarte-Mata Diana Ivonne· 1 shared Erwan PoliD· 1 shared Estefanía Alemán-Navarro· 1 shared Gilles HuberfeldiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Adrien Bouchet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NKCC1 as a signaling hub regulating KCC2 stability, chloride homeostasis, and seizure susceptibility

Erwan Pol, Célia Delhaye, Silvia Cases‐Cunillera, Marion Russeau, Simon Blachier, Adrien Bouchet, Christophe Piesse, Johan Pallud, Gilles Huberfeld, Nicolas Pietrancosta, Sabine Lévi

The paper identifies NKCC1 as a signaling hub that regulates KCC2 stability and chloride homeostasis, showing that peptides targeting NKCC1 can reduce seizure frequency in epilepsy.

bioRxiv · Dec 9, 2025 · PreprintNeuroscience

Dermaseptin DMS-DA6, a promising alternative to conventional antibiotic in the treatment of N. brasiliensis induced actinomycetoma

Constance Auvynet, Duarte-Mata Diana Ivonne, Anna Velia Vázquez-Marmolejo, Estefanía Alemán-Navarro, Christophe Piesse, Yvonne Rosenstein, Mario Cesar Salinas-Carmona

This study compares the efficacy of the host defense peptide DMS-DA6 with the antibiotic linezolid in treating N. brasiliensis-induced actinomycetoma in mice, finding DMS-DA6 more effective at lower doses and fewer injections.

bioRxiv · Jun 16, 2025 · PreprintMicrobiology